• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Prospect Capital Corporation (Amendment)

    3/22/24 4:58:04 PM ET
    $PSEC
    Finance: Consumer Services
    Finance
    Get the next $PSEC alert in real time by email
    SC 13D/A 1 a20240322-johnbarrysc13da.htm SC 13D/A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D/A
    Under the Securities Exchange Act of 1934
    (Amendment No. 9)*†

    Prospect Capital Corporation
    __________________________________________________________________________________
    (Name of Issuer)

    Common Stock, par value $ 0.001 per share
    __________________________________________________________________________________
    (Title of Class of Securities)

    74348T102
    __________________________________________________________________________________
    (CUSIP Number)

    John F. Barry III
    700 S. Rosemary Avenue, Suite 204
    West Palm Beach, FL 33401
    212-448-1858
    __________________________________________________________________________________
    (Name, Address and Telephone Number of Person Authorized to
    Receive Notices and Communications)
    March 20, 2024
    _________________________________________________________________________________
    (Date of Event which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule.13d-7 for other parties to whom copies are to be sent.




    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    † This Schedule 13D/A constitutes Amendment No.7 to the Schedule 13D filed on behalf of the John and Daria Barry Foundation and Amendment No. 9 to the Schedule 13D of John F. Barry III originally filed with the SEC on February 29, 2016, as amended by Amendment No. 1 filed with the SEC on November 21, 2017, Amendment No. 2 filed with the SEC on November 28, 2017, Amendment No. 3 filed with the SEC on December 29, 2017, Amendment No. 4 filed with the SEC on July 2, 2018, Amendment No. 5 filed with the SEC on January 7, 2019, Amendment No. 6 filed with the SEC on March 23, 2020, Amendment No. 7 filed with the SEC on July 6, 2020, and Amendment No. 8 filed with the SEC on January 8, 2021.



    CUSIP No. 74348T102
    1.  Names of Reporting Persons.
     John F. Barry III
    2.  Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
    3.  SEC Use Only
    4.  Source of Funds
            BK, PF, OO
    5.  Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
    6.  Citizenship or Place of Organization
        United States of America


       Number of Shares
       Beneficially
       Owned by
       Each Reporting
       Person With:
    7.  Sole Voting Power
    108,708,751.33
    8.  Shared Voting Power
    300,272.93
    9.  Sole Dispositive Power
    108,708,751.33
    10.  Shared Dispositive Power
    300,272.93
    11.  Aggregate Amount Beneficially Owned by Each Reporting Person
      109,009,024.26
    12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares o
    13.  Percent of Class Represented by Amount in Row (11)
            26.25%
    14.  Type of Reporting Person
            IN



    CUSIP No. 74348T102
    1.  Names of Reporting Persons.
     John and Daria Barry Foundation
    2.  Check the Appropriate Box if a Member of a Group
    (a) o
    (b) o
    3.  SEC Use Only
    4.  Source of Funds
            OO, WC
    5.  Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
    6.  Citizenship or Place of Organization
        United States of America


       Number of Shares
       Beneficially
       Owned by
       Each Reporting
       Person With:
    7.  Sole Voting Power
          43,727,065.61
    8.  Shared Voting Power
           0
    9.  Sole Dispositive Power
           43,727,065.61
    10.  Shared Dispositive Power
           0
    11.  Aggregate Amount Beneficially Owned by Each Reporting Person
               43,727,065.61
    12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares o
    13.  Percent of Class Represented by Amount in Row (11)
            10.53%
    14.  Type of Reporting Person
            OO




    This Schedule 13D/A constitutes Amendment No. 7 to the Schedule 13D on behalf of the John and Daria Barry Foundation (the “Foundation”) and Amendment No. 9 to the Schedule 13D of John F. Barry III originally filed with the SEC on February 29, 2016 (the “Original Schedule 13D”), as amended by Amendment No. 1 filed with the SEC on November 21, 2017 (“Amendment No. 1”), Amendment No. 2 filed with the SEC on November 28, 2017 (“Amendment No. 2”), Amendment No. 3 filed with the SEC on December 29, 2017 (“Amendment No. 3”), Amendment No. 4 filed with the SEC on July 2, 2018 (“Amendment No.4”), Amendment No. 5 filed with the SEC on January 7, 2019 (“Amendment No. 5”), Amendment No. 6 filed with SEC on March 23, 2020 (“Amendment No. 6”), Amendment No. 7 filed with the SEC on July 6, 2020 (“Amendment No. 7”) and Amendment No. 8 filed with the SEC on January 8, 2021 (“Amendment No. 8”). Except as expressly set forth herein, there have been no changes in the information set forth in the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7 or Amendment No. 8, and such prior disclosure, as so amended, is incorporated into this Amendment No. 7 to the Schedule 13D on behalf of the Foundation and Amendment No. 9 to the Schedule 13D of John F. Barry III.

    ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
    Item 3 is amended by adding the following:

    Since the filing of Amendment No. 8 on January 8, 2021 through March 22, 2024: (i) Mr. Barry acquired an aggregate of 3,339,623.36 Shares, which include Shares held in an IRA account in his name (the "John F. Barry III IRA”) and consist of 3,016,943.36 Shares purchased with dividends through the Issuer’s dividend reinvestment plan and 382,680 Shares purchased with personal funds on the open market; (ii) 83,434.85 Shares were purchased with dividends through the Issuer’s dividend reinvestment account by an IRA account controlled by Mr. Barry’s spouse, Daria Barry (the “Daria Barry IRA”); and (iii) the Foundation acquired an aggregate of 1,015,520.59 Shares, which consist of 1,015,520.59 Shares purchased with dividends through the Issuer’s dividend reinvestment plan and 0 Shares purchased with existing cash on hand on the open market.

    ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

    Item 5 is amended and restated as follows:

    (a)-(b) The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated herein by reference. The percentage set forth in row 13 is based on 415,207,492 outstanding Shares as of March 12, 2024, as reported in the Issuer’s Schedule 14A filed on March 12, 2024. Mr. Barry has sole voting and dispositive power over the 108,708,751.33 Shares held by him directly and through the Foundation as of March 22, 2024. Mr. Barry has shared voting and dispositive power over the 300,272.93 Shares acquired through the Daria Barry IRA.

    (c) The following table sets forth all other transactions with respect to shares effected during the past sixty days by Mr. Barry and the Foundation. Except as otherwise noted below, all such transactions were purchases of shares effected in the open market, and the table includes commissions paid in per share prices.




    Date of TransactionAccount Amount of Securities Weighted Average Price per ShareType
    3/20/2024John F. Barry III IRA11,458.90$5.206Dividend
    3/20/2024John F. Barry III72.79$5.206Dividend
    3/20/2024Daria Barry IRA3,248.65$5.206Dividend
    2/20/2024John F. Barry III IRA10,661.68$5.5385Dividend
    2/20/2024Daria Barry IRA3,022.64$5.5385Dividend

    (d) Not applicable.

    (e) Not applicable.





    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: March 22, 2024


    By:    /s/ John F. Barry III
    Name:    John F. Barry III


    JOHN AND DARIA BARRY FOUNDATION


    By:    /s/ John F. Barry III
    Name:    John F. Barry III
    Title:     Trustee


    Get the next $PSEC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PSEC

    DatePrice TargetRatingAnalyst
    11/9/2021Underperform → Market Perform
    Raymond James
    8/26/2021$6.00 → $6.50Underweight
    Wells Fargo
    More analyst ratings